Udo Eichenlaub
Impact in
- Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research
- Physiology top 1%
- Alzheimer's disease research and treatments
- Clinical Laboratory Practices and Quality Control
Papers in
-
- Dementia and Cognitive Impairment Research 26
- Physiology 16
- Alzheimer's disease research and treatments 15
- Clinical Laboratory Practices and Quality Control 3
- Co-authors
- Kaj Blennow (15 shared papers)Henrik Zetterberg (11 shared papers)Oskar Hansson (10 shared papers)Erik Stomrud (7 shared papers)Shorena Janelidze (6 shared papers)Niklas Mattsson (6 shared papers)Sebastian Palmqvist (5 shared papers)Tobias Bittner (9 shared papers)
- Journals
- Alzheimer s & Dementia (19 papers)JAMA Neurology (3 papers)Infectious Diseases and Therapy (1 paper)Nature Medicine (1 paper)Alzheimer s Research & Therapy (1 paper)
- Partner nations
- United StatesSwedenSwitzerland
In The Last Decade
Udo Eichenlaub
36 papers receiving 3.7k citations
Udo Eichenlaub's Hit Papers
Peers
Comparison fields: 5 of 91
- Psychiatry and Mental health 2.7k
- Physiology 1.7k
- Neurology 109
- Neurology 107
- Developmental Neuroscience 12
Countries citing papers authored by Udo Eichenlaub
This map shows the geographic impact of Udo Eichenlaub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Eichenlaub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Eichenlaub more than expected).
Fields of papers citing papers by Udo Eichenlaub
This network shows the impact of papers produced by Udo Eichenlaub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Eichenlaub. The network helps show where Udo Eichenlaub may publish in the future.
Co-authors
The 25 scholars most cited alongside Udo Eichenlaub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia Hit paper breakdown → | 2020 | 961 |
| 2 | CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts Hit paper breakdown → | 2018 | 619 |
| 3 | Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease Hit paper breakdown → | 2021 | 371 |
| 4 | Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status Hit paper breakdown → | 2019 | 345 |
| 5 | 2015 | 295 | |
| 6 | Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease Hit paper breakdown → | 2019 | 290 |
| 7 | Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease Hit paper breakdown → | 2022 | 181 |
| 8 | 2019 | 156 | |
| 9 | An accurate fully automated panel of plasma biomarkers for Alzheimer's disease Hit paper breakdown → | 2022 | 127 |
| 10 | 2021 | 75 | |
| 11 | 2018 | 64 | |
| 12 | 2015 | 54 | |
| 13 | 2022 | 45 | |
| 14 | 2022 | 44 | |
| 15 | 2021 | 41 | |
| 16 | 2021 | 22 | |
| 17 | 2020 | 16 | |
| 18 | 2013 | 10 | |
| 19 | 2015 | 10 | |
| 20 | 2017 | 9 |
About Udo Eichenlaub
Udo Eichenlaub is a scholar working on Psychiatry and Mental health, Physiology, Infectious Diseases, Health, Toxicology and Mutagenesis and Cellular and Molecular Neuroscience, having authored 37 papers that have together received 3.8k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (26 papers), Alzheimer's disease research and treatments (15 papers), Clinical Laboratory Practices and Quality Control (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cerebrospinal fluid and hydrocephalus (1 paper), Cytomegalovirus and herpesvirus research (1 paper) and Air Quality and Health Impacts (1 paper). The work is most often cited by research in Psychiatry and Mental health (2.7k citations), Physiology (1.7k citations), Neurology (109 citations), Neurology (107 citations) and Developmental Neuroscience (12 citations). Udo Eichenlaub has collaborated with scholars based in United States, Sweden and Switzerland. Frequent co-authors include Kaj Blennow, Henrik Zetterberg, Oskar Hansson, Erik Stomrud, Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Tobias Bittner, Jeff L. Dage and Xiyun Chai. Their work appears in journals such as Alzheimer s & Dementia, JAMA Neurology, Infectious Diseases and Therapy, Nature Medicine and Alzheimer s Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.